Page last updated: 2024-08-24

irinotecan and Adrenal Cortex Cancer

irinotecan has been researched along with Adrenal Cortex Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bachelot, A; Baudin, E; Docao, C; Gicquel, C; Penfornis, A; Schlumberger, M; Vassal, G	1

Trials

1 trial(s) available for irinotecan and Adrenal Cortex Cancer

Article	Year
Use of a topoisomerase I inhibitor (irinotecan, CPT-11) in metastatic adrenocortical carcinoma. Annals of oncology : official journal of the European Society for Medical Oncology, 2002, Volume: 13, Issue:11 Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Adult; Biopsy, Needle; Camptothecin; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; France; Humans; Infusions, Intravenous; Irinotecan; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Sensitivity and Specificity; Survival Rate; Treatment Outcome	2002

Article

Year

Use of a topoisomerase I inhibitor (irinotecan, CPT-11) in metastatic adrenocortical carcinoma.

Annals of oncology : official journal of the European Society for Medical Oncology, 2002, Volume: 13, Issue:11

Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Adult; Biopsy, Needle; Camptothecin; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; France; Humans; Infusions, Intravenous; Irinotecan; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Sensitivity and Specificity; Survival Rate; Treatment Outcome

2002